Latest filing published 18 Jan 2019 for RepliCel Life Sciences Inc., €18k.
No signal scores available.
This profile gathers the share dealings of Geoffrey MacKay in RepliCel Life Sciences Inc. Between 14 October 2015 and 15 January 2019, the trades on record add up to 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 18 January 2019, the filings show a transaction worth €18k in RepliCel Life Sciences Inc. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations